| 2026 |
| 10/27 | 3,275 | 3,280 | 3,235 | 3,250 | -0.76% | 35,400 | - | +1.31% |
| 10/26 | （IR情報）14:00 妊娠に伴う悪心・嘔吐に対するBON-001の日本における第III相臨床試験開始に関するお知らせ |
| 10/26 | 3,280 | 3,305 | 3,255 | 3,275 | -0.3% | 39,300 | - | +2.06% |
| 10/23 | 3,295 | 3,330 | 3,255 | 3,285 | +0.61% | 51,400 | - | +2.4% |
| 10/22 | 3,270 | 3,285 | 3,250 | 3,265 | +0.93% | 32,100 | - | +1.84% |
| 10/21 | 3,270 | 3,280 | 3,235 | 3,235 | -0.31% | 39,200 | - | +1.06% |
| 10/20 | 3,225 | 3,245 | 3,215 | 3,245 | +0.62% | 24,300 | - | +1.44% |
| 10/19 | 3,275 | 3,290 | 3,210 | 3,225 | -1.53% | 60,300 | - | +0.91% |
| 10/16 | 3,225 | 3,285 | 3,225 | 3,275 | +0.92% | 49,800 | - | +2.5% |
| 10/15 | 3,160 | 3,245 | 3,145 | 3,245 | +3.18% | 72,300 | - | +1.66% |
| 10/14 | 3,165 | 3,165 | 3,130 | 3,145 | -0.79% | 25,600 | - | -1.47% |
| 10/13 | 3,080 | 3,170 | 3,080 | 3,170 | +3.09% | 50,900 | - | -0.88% |
| 10/09 | 3,090 | 3,110 | 3,070 | 3,075 | -0.16% | 53,500 | - | -3.97% |
| 10/08 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 10/08 | 3,120 | 3,120 | 3,080 | 3,080 | -0.96% | 56,300 | - | -4.11% |
| 10/07 | 3,115 | 3,125 | 3,100 | 3,110 | -0.64% | 33,600 | - | -3.42% |
| 10/06 | 3,090 | 3,130 | 3,090 | 3,130 | +1.29% | 34,000 | - | -3.01% |
| 10/05 | 3,085 | 3,105 | 3,070 | 3,090 | 0% | 47,400 | - | -4.42% |
| 10/02 | 3,150 | 3,150 | 3,080 | 3,090 | -2.83% | 66,800 | - | -4.72% |
| 10/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 10/01 | 3,170 | 3,180 | 3,140 | 3,180 | 0% | 51,800 | - | -2.21% |
| 09/30 | 3,180 | 3,190 | 3,125 | 3,180 | -0.16% | 52,600 | - | -2.3% |
| 09/29 | 3,240 | 3,240 | 3,165 | 3,185 | -2.3% | 39,100 | - | -2.27% |
| 09/28 | 3,290 | 3,290 | 3,255 | 3,260 | -1.21% | 40,700 | - | -0.06% |
| 09/25 | 3,270 | 3,310 | 3,270 | 3,300 | +0.61% | 31,400 | - | +1.2% |
| 09/24 | 3,340 | 3,340 | 3,280 | 3,280 | -0.61% | 51,800 | - | +0.68% |
| 09/18 | 3,340 | 3,340 | 3,300 | 3,300 | -0.9% | 51,600 | - | +1.41% |
| 09/17 | 3,285 | 3,330 | 3,275 | 3,330 | +1.83% | 57,600 | - | +2.4% |
| 09/16 | 3,260 | 3,290 | 3,225 | 3,270 | +0.62% | 37,200 | - | +0.65% |
| 09/15 | 3,225 | 3,265 | 3,225 | 3,250 | +0.78% | 35,100 | - | +0.09% |
| 09/14 | 3,160 | 3,235 | 3,160 | 3,225 | +2.06% | 28,900 | - | -0.68% |
| 09/11 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 09/11 | 3,140 | 3,170 | 3,135 | 3,160 | -0.47% | 56,700 | - | -2.65% |
| 09/10 | 3,170 | 3,190 | 3,165 | 3,175 | -0.16% | 33,900 | - | -2.16% |
| 09/09 | 3,190 | 3,205 | 3,175 | 3,180 | -0.16% | 33,700 | - | -1.88% |
| 09/08 | 3,200 | 3,225 | 3,175 | 3,185 | -0.62% | 29,600 | - | -1.67% |
| 09/07 | 3,250 | 3,250 | 3,200 | 3,205 | -1.54% | 31,300 | - | -1.02% |
| 09/04 | 3,280 | 3,285 | 3,245 | 3,255 | -0.91% | 42,200 | - | +0.62% |
| 09/03 | 3,295 | 3,315 | 3,280 | 3,285 | +0.15% | 33,600 | - | +1.58% |
| 09/02 | 3,290 | 3,315 | 3,280 | 3,280 | -0.91% | 41,500 | - | +1.49% |
| 09/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 09/01 | 3,285 | 3,325 | 3,280 | 3,310 | +0.91% | 31,400 | - | +2.51% |
| 08/31 | 3,270 | 3,300 | 3,270 | 3,280 | -0.3% | 87,200 | - | +1.74% |
| 08/28 | 3,290 | 3,320 | 3,280 | 3,290 | 0% | 40,200 | - | +2.24% |
| 08/27 | 3,335 | 3,335 | 3,280 | 3,290 | -1.35% | 35,400 | - | +2.46% |
| 08/26 | 3,305 | 3,340 | 3,300 | 3,335 | +0.76% | 38,700 | - | +4.06% |
| 08/25 | 3,265 | 3,315 | 3,265 | 3,310 | +1.38% | 52,000 | - | +3.53% |
| 08/24 | 3,285 | 3,305 | 3,260 | 3,265 | +0.15% | 35,000 | - | +2.38% |
| 08/21 | 3,280 | 3,285 | 3,250 | 3,260 | -0.61% | 43,700 | - | +2.42% |
| 08/20 | 3,240 | 3,280 | 3,230 | 3,280 | +1.86% | 58,900 | - | +3.21% |
| 08/19 | （IR情報）16:00 トピロリック錠の製造販売承認の承継および資産譲受のお知らせ |
| 08/19 | 3,225 | 3,235 | 3,190 | 3,220 | 0% | 42,500 | - | +1.51% |
| 08/18 | 3,190 | 3,240 | 3,190 | 3,220 | +0.78% | 35,800 | - | +1.67% |
| 08/17 | 3,255 | 3,255 | 3,180 | 3,195 | -1.69% | 42,500 | - | +0.98% |
| 08/14 | 3,240 | 3,260 | 3,230 | 3,250 | 0% | 40,400 | - | +2.82% |
| 08/13 | 3,225 | 3,250 | 3,215 | 3,250 | +0.78% | 33,400 | - | +2.91% |
| 08/12 | 3,250 | 3,250 | 3,215 | 3,225 | -0.46% | 38,900 | - | +2.25% |
| 08/10 | 3,230 | 3,250 | 3,205 | 3,240 | +0.93% | 38,700 | - | +2.79% |
| 08/07 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 08/07 | 3,135 | 3,230 | 3,125 | 3,210 | +2.39% | 68,900 | - | +1.97% |
| 08/06 | 3,100 | 3,150 | 3,090 | 3,135 | +2.12% | 89,100 | - | -0.35% |
| 08/05 | 3,145 | 3,150 | 3,070 | 3,070 | -1.6% | 93,300 | - | -2.45% |
| 08/04 | 3,175 | 3,175 | 3,090 | 3,120 | -1.89% | 128,000 | - | -1.02% |
| 08/03 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 08/03 | （IR情報）14:00 2027年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/03 | 3,170 | 3,245 | 3,075 | 3,180 | +1.92% | 143,900 | - | +0.79% |
| 07/31 | 3,240 | 3,245 | 3,120 | 3,120 | -3.41% | 68,900 | - | -1.05% |
| 07/30 | 3,245 | 3,255 | 3,180 | 3,230 | -0.46% | 66,200 | - | +2.41% |
| 07/29 | 3,195 | 3,270 | 3,175 | 3,245 | +1.88% | 71,600 | - | +2.89% |
| 07/28 | 3,190 | 3,200 | 3,160 | 3,185 | -0.31% | 51,600 | - | +1.08% |
| 07/27 | 3,155 | 3,200 | 3,145 | 3,195 | +2.4% | 66,300 | - | +1.49% |
| 07/24 | 3,120 | 3,135 | 3,105 | 3,120 | 0% | 44,900 | - | -0.86% |
| 07/23 | 3,140 | 3,140 | 3,105 | 3,120 | -0.64% | 65,200 | - | -0.92% |
| 07/22 | 3,145 | 3,165 | 3,125 | 3,140 | -0.16% | 58,700 | - | -0.25% |
| 07/21 | 3,135 | 3,170 | 3,115 | 3,145 | +0.96% | 66,800 | - | -0.1% |
| 07/17 | 3,120 | 3,145 | 3,100 | 3,115 | +0.16% | 51,600 | - | -1.05% |
| 07/16 | 3,155 | 3,175 | 3,110 | 3,110 | -0.96% | 53,800 | - | -1.3% |
| 07/15 | 3,130 | 3,155 | 3,120 | 3,140 | +0.8% | 52,900 | - | -0.48% |
| 07/14 | 3,130 | 3,150 | 3,110 | 3,115 | +0.16% | 54,200 | - | -1.33% |
| 07/13 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 07/13 | 3,155 | 3,155 | 3,110 | 3,110 | -0.8% | 62,300 | - | -1.61% |
| 07/10 | 3,160 | 3,160 | 3,130 | 3,135 | +0.16% | 49,100 | - | -0.92% |
| 07/09 | 3,165 | 3,165 | 3,130 | 3,130 | -0.79% | 45,900 | - | -1.14% |
| 07/08 | 3,170 | 3,185 | 3,155 | 3,155 | 0% | 70,600 | - | -0.38% |
| 07/07 | 3,175 | 3,195 | 3,130 | 3,155 | -0.47% | 163,500 | - | -0.38% |
| 07/06 | 3,185 | 3,210 | 3,160 | 3,170 | +0.63% | 59,900 | - | +0.03% |
| 07/03 | 3,200 | 3,245 | 3,150 | 3,150 | -0.47% | 51,400 | - | -0.85% |
| 07/02 | 3,210 | 3,220 | 3,165 | 3,165 | +0.16% | 47,100 | - | -0.75% |
| 07/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
| 07/01 | （IR情報）14:00 痛風・高尿酸血症治療剤「ユリス錠」の小児に対する用法・用量追加の承認事項一部変更承認申請のお知らせ |
| 07/01 | 3,175 | 3,190 | 3,155 | 3,160 | -0.94% | 49,400 | - | -1.22% |
| 06/30 | 3,195 | 3,220 | 3,180 | 3,190 | -0.16% | 66,000 | - | -0.65% |
| 06/29 | 3,175 | 3,220 | 3,165 | 3,195 | +1.91% | 63,900 | - | -0.9% |
| 06/26 | 3,165 | 3,170 | 3,135 | 3,135 | -0.16% | 54,900 | - | -3.15% |
| 06/25 | 3,225 | 3,235 | 3,140 | 3,140 | -2.94% | 65,700 | - | -3.62% |
| 06/24 | 3,180 | 3,260 | 3,180 | 3,235 | +2.54% | 52,700 | - | -1.31% |
| 06/23 | 3,115 | 3,175 | 3,105 | 3,155 | +0.8% | 46,400 | - | -4.13% |
| 06/22 | 3,135 | 3,165 | 3,120 | 3,130 | -0.63% | 42,700 | - | -5.32% |
| 06/19 | 3,170 | 3,175 | 3,125 | 3,150 | -0.79% | 86,100 | - | -5.12% |
| 06/18 | 3,140 | 3,190 | 3,105 | 3,175 | +2.09% | 66,300 | - | -4.68% |
| 06/17 | 3,125 | 3,145 | 3,095 | 3,110 | -0.48% | 74,100 | - | -6.8% |
| 06/16 | 3,140 | 3,145 | 3,095 | 3,125 | -0.79% | 48,900 | - | -6.66% |
| 06/15 | 3,230 | 3,240 | 3,150 | 3,150 | -1.56% | 43,000 | - | -6.22% |
| 06/12 | （自社株買い）取締役会(2026年3月30日)での決議状況(取得期間2026年5月18日～2026年12月18日) |
| 06/12 | 3,190 | 3,205 | 3,175 | 3,200 | +0.16% | 48,300 | - | -5.07% |
| 06/11 | 3,215 | 3,215 | 3,130 | 3,195 | +0.16% | 42,000 | - | -5.45% |
| 06/10 | 3,215 | 3,250 | 3,175 | 3,190 | -0.78% | 40,900 | - | -5.84% |
| 06/09 | 3,205 | 3,225 | 3,195 | 3,215 | +0.47% | 40,300 | - | -5.3% |
| 06/08 | 3,185 | 3,240 | 3,175 | 3,200 | +0.63% | 56,000 | - | -5.91% |
| 06/05 | 3,195 | 3,220 | 3,180 | 3,180 | +1.11% | 39,500 | - | -6.66% |
| 06/04 | 3,150 | 3,180 | 3,120 | 3,145 | -0.32% | 61,500 | - | -7.88% |
| 06/03 | 3,205 | 3,205 | 3,130 | 3,155 | -1.71% | 53,400 | - | -7.86% |
| 06/02 | 3,325 | 3,325 | 3,210 | 3,210 | -4.61% | 57,100 | - | -6.55% |
| 06/01 | （IR情報）14:00 自己株式の取得状況に関するお知らせ |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
